Abstract:SORLA is a transmembrane trafficking protein associated with Alzheimer's disease risk. Although SORLA is abundantly expressed in neurons, physiological roles for SORLA remain unclear. Here, we show that cultured transgenic neurons overexpressing SORLA feature longer neurites, and accelerated neurite regeneration with wounding. Enhanced release of a soluble form of SORLA (sSORLA) is observed in transgenic mouse neurons overexpressing human SORLA, while purified sSORLA promotes neurite extension and regeneration. Phosphoproteomic analyses demonstrate enrichment of phosphoproteins related to the epidermal growth factor (EGFR)/ERK pathway in SORLA transgenic mouse hippocampus from both genders. sSORLA coprecipitates with EGFR in vitro, and sSORLA treatment increases EGFR Y1173 phosphorylation, which is involved in ERK activation in cultured neurons. Furthermore, sSORLA triggers ERK activation, whereas pharmacological EGFR or ERK inhibition reverses sSORLA-dependent enhancement of neurite outgrowth. In search for downstream ERK effectors activated by sSORLA, we identified upregulation of Fos expression in hippocampus from male mice overexpressing SORLA by RNAseq analysis. We also found that Fos is upregulated and translocates to the nucleus in an ERK-dependent manner in neurons treated with sSORLA. Together, these results demonstrate that sSORLA is an EGFR-interacting protein that activates EGFR/ERK/Fos signaling to enhance neurite outgrowth and regeneration. SIGNIFICANCE STATEMENT SORLA is a transmembrane trafficking protein previously known to reduce the levels of amyloid-β, which is critical in the pathogenesis of Alzheimer's disease. In addition, SORLA mutations are a risk factor for Alzheimer's disease. Interestingly, the SORLA ectodomain is cleaved into a soluble form, sSORLA, which has been shown to regulate cytoskeletal signaling pathways and cell motility in cells outside the nervous system. We show here that sSORLA binds and activates the EGF receptor to induce downstream signaling through the ERK serine/threonine kinase and the Fos transcription factor, thereby enhancing neurite outgrowth. These findings reveal a novel role for sSORLA in promoting neurite regeneration through the EGF receptor/ERK/Fos pathway, thereby demonstrating a potential neuroprotective mechanism involving SORLA.

Snx27 and Sorla Interact to Reduce Amyloidogenic Subcellular Distribution and Processing of Amyloid Precursor Protein

SORLA Attenuates EphA4 Signaling and Amyloid Β–induced Neurodegeneration

The Role of SORL1 in Alzheimer’s Disease

SNX15 Regulates Cell Surface Recycling of APP and Aβ Generation

Endo-Lysosomal Network Disorder Reprograms Energy Metabolism in SorL1-Null Rat Hippocampus

SNX8 Enhances Non-amyloidogenic APP Trafficking and Attenuates Aβ Accumulation and Memory Deficits in an AD Mouse

The Alzheimer's disease gene SORL1 regulates lysosome function in human microglia

Sorting Nexin 12 Interacts with BACE1 and Regulates BACE1-mediated APP Processing

Soluble SORLA Enhances Neurite Outgrowth and Regeneration Through Activation of the EGF Receptor/ERK Signaling Axis

Reduction of Sortilin-1 in Alzheimer Hippocampus and in Cytokine-Stressed Human Brain Cells

Sorting Nexin 27 Regulates Aβ Production Through Modulating Γ-Secretase Activity

Neurobiology of Disease SNX 27 and SORLA Interact to Reduce Amyloidogenic Subcellular Distribution and Processing of Amyloid Precursor Protein

Risk factor SORL1: from genetic association to functional validation in Alzheimer’s disease

Roles of SNX Family Members in Neurodegenerative Diseases

Differential effects of SORL1 deficiency on the endo-lysosomal network in human neurons and microglia

Down-regulation of SORL1 is associated with Alzheimer's disease through activating ABC transporter pathway

SNX12 Affects Aβ Generation Through Regulating Subcellular Localization of BACE1

Interaction Between Amyloid Precursor Protein and Nogo Receptors Regulates Amyloid Deposition

Exosomes Mediate APP Dysregulation <i>via</i> APP-miR-185-5p Axis

A Study of the SORL1 Gene in the Pathogenesis of Late-onset Alzheimer’s Disease by Affecting the Expression of BDNF

A GPCR/secretase Complex Regulates Β- and Γ-Secretase Specificity for Aβ Production and Contributes to AD Pathogenesis